Results 11 to 20 of about 1,420,864 (247)

The Role of Cannabinoid Receptors in the Descending Modulation of Pain

open access: yesPharmaceuticals, 2010
The endogenous antinociceptive descending pathway represents a circuitry of the supraspinal central nervous system whose task is to counteract pain. It includes the periaqueductal grey (PAG)-rostral ventromedial medulla (RVM)-dorsal horn (DH) axis, which
Francesco Rossi   +4 more
doaj   +4 more sources

Cholesterol as a modulator of cannabinoid receptor CB2 signaling [PDF]

open access: yesScientific Reports, 2021
Signaling through integral membrane G protein-coupled receptors (GPCRs) is influenced by lipid composition of cell membranes. By using novel high affinity ligands of human cannabinoid receptor CB2, we demonstrate that cholesterol increases basal ...
Alexei Yeliseev   +7 more
doaj   +3 more sources

The development and therapeutic potential of classical and next-generation cannabinoid ligands

open access: yesPharmacological Research
The endogenous cannabinoid system (ECS) is a complex network that plays a crucial role in various physiological processes, and its modulation through cannabinoid ligands has garnered significant interest in pharmacological research. Cannabinoid receptors,
Verónica Muñoz-Canales   +4 more
doaj   +2 more sources

In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators

open access: yesMolecules, 2022
Although the 3D structures of active and inactive cannabinoid receptors type 2 (CB2) are available, neither the X-ray crystal nor the cryo-EM structure of CB2-orthosteric ligand-modulator has been resolved, prohibiting the drug discovery and development ...
Jiayi Yuan   +7 more
doaj   +1 more source

Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities [PDF]

open access: yes, 2017
Cannabinoid pharmacology has been intensely studied because of cannabis' pervasive medicinal and non-medicinal uses as well as for the therapeutic potential of cannabinoid-based drugs for the treatment of pain, anxiety, substance abuse, obesity, cancer ...
Piomelli, D   +10 more
core   +3 more sources

Cannabinoids for the control of experimental multiple sclerosis [PDF]

open access: yes, 2010
PhDThere have been numerous studies reporting that cannabinoids, both exogenous and endogenous, have a potential beneficial function during incidences of neurological damage.
Pryce, Gareth
core   +4 more sources

Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor. [PDF]

open access: yesInt J Mol Sci
Cannabinoid receptors CB1R and CB2R are G-protein coupled receptors acted upon by endocannabinoids (eCBs), namely 2-arachidonoylglycerol (2-AG) and N-arachidonoyl ethanolamine (AEA), with unique pharmacology and modulate disparate physiological processes.
Shivshankar S   +3 more
europepmc   +2 more sources

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism [PDF]

open access: yes, 2020
The manuscript of a paper entitled "Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism".
Anton, Bashilov   +5 more
core   +2 more sources

The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system [PDF]

open access: yes, 2008
INTRODUCTION: Ghrelin and cannabinoids stimulate appetite, this effect possibly being mediated by the activation of hypothalamic AMP-activated protein kinase (AMPK), a key enzyme in appetite and metabolism regulation. The cannabinoid receptor type 1 (CB1)
Judith Harvey-White   +59 more
core   +3 more sources

Discovery and development of macrocyclic peptide modulators of the cannabinoid 2 receptor. [PDF]

open access: yes
The cannabinoid-type 2 receptor (CB2R), a G protein-coupled receptor (GPCR), is an important regulator of immune cell function and a promising target to treat chronic inflammation and fibrosis.
Muratspahić, Edin   +10 more
core   +6 more sources

Home - About - Disclaimer - Privacy